ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,960Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 807

$653K Total Retail Price of All Prescriptions

Rank: 51 out of 807

718 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 718 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 718 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 9,698 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 789 669 1 1
LISINOPRIL 545 458 2 2
OMEPRAZOLE 408 290 3 4
FUROSEMIDE 401 330 4 6
LEVOTHYROXINE SODIUM 395 269 5 3
METOPROLOL TARTRATE 388 343 6 8
AMLODIPINE BESYLATE 323 291 7 5
METOPROLOL SUCCINATE 274 260 8 13
METFORMIN HCL 243 179 9 12
ATORVASTATIN CALCIUM 224 206 10 11
HYDROCODONE-ACETAMINOPHEN 217 160 S3 11 15
POTASSIUM CHLORIDE 212 164 12 18
JANTOVEN 195 170 13 37
ATENOLOL 178 151 14 7
TRIAMTERENE-HCTZ 154 136 15 29
LOSARTAN POTASSIUM 154 142 15 14
LANTUS 138 92 17 45
WARFARIN SODIUM 132 117 18 10
HYDROCHLOROTHIAZIDE 131 127 19 9
CITALOPRAM HBR 128 109 20 17
SERTRALINE HCL 128 97 20 22
LOVASTATIN 128 122 20 39
GABAPENTIN 119 73 23 16
ALLOPURINOL 114 101 24 26
PREDNISONE 113 102 25 24
TRAMADOL HCL 101 56 26 19
TAMSULOSIN HCL 99 90 27 27
PANTOPRAZOLE SODIUM 94 77 28 44
LANTUS SOLOSTAR 92 81 29 42
FLUOXETINE HCL 89 79 30 52
OXYCODONE HCL 89 66 S2 30 53
GLIPIZIDE ER 79 62 32 67
ZETIA 76 66 33 59
PROAIR HFA 74 35 34 43
ISOSORBIDE MONONITRATE ER 73 63 35 36
CLOPIDOGREL 72 72 36 47
PRAVASTATIN SODIUM 67 53 37 21
HYDRALAZINE HCL 64 61 38 62
ALENDRONATE SODIUM 63 59 39 20
SPIRIVA 62 51 40 50
PEN NEEDLE 61 61 41 63
DIGOXIN 61 61 41 41
ZOLPIDEM TARTRATE 61 61 41 23
OXYCODONE-ACETAMINOPHEN 60 49 S2 44 56
OXYBUTYNIN CHLORIDE 59 36 45 108
SPIRONOLACTONE 59 32 45 48
GLIPIZIDE 59 47 45 58
CRESTOR 57 42 48 32
POLYETHYLENE GLYCOL 3350 56 55 49 40
PROPRANOLOL HCL 56 30 49 101
RANITIDINE HCL 54 52 51 34
CLONIDINE HCL 53 49 52 82
FLUTICASONE PROPIONATE 53 42 52 30
CARVEDILOL 52 51 54 35
PLAVIX 52 52 54 60
VENTOLIN HFA 52 49 54 152
HUMALOG 52 38 54 124
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.